These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30609077)

  • 21. Time until diagnosis of clinical events with different remote monitoring systems in implantable cardioverter-defibrillator patients.
    Söth-Hansen M; Witt CT; Rasmussen M; Kristensen J; Gerdes C; Nielsen JC
    Heart Rhythm; 2018 Nov; 15(11):1648-1654. PubMed ID: 29803850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of remote monitoring on the management of arrhythmias in patients with implantable cardioverter-defibrillator.
    Marcantoni L; Toselli T; Urso G; Pratola C; Ceconi C; Bertini M
    J Cardiovasc Med (Hagerstown); 2015 Nov; 16(11):775-81. PubMed ID: 25032715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of remote monitoring in the management of ICD end-of-life: Data from the DECODE registry.
    Campana A; Giofrè F; Stabile G; Iori M; La Rosa C; Tomasi C; Calzolari V; Miracapillo G; Notarstefano P; Carinci V; Calò L; Ferretti C; Manzo M; Malacrida M; Biffi M
    Int J Cardiol; 2016 Oct; 221():430-2. PubMed ID: 27409569
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder.
    Drak-Hernández Y; Toquero-Ramos J; Fernández JM; Pérez-Pereira E; Castro-Urda V; Fernández-Lozano I
    Rev Esp Cardiol (Engl Ed); 2013 Dec; 66(12):943-8. PubMed ID: 24774107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial.
    Guédon-Moreau L; Kouakam C; Klug D; Marquié C; Brigadeau F; Boulé S; Blangy H; Lacroix D; Clémenty J; Sadoul N; Kacet S
    J Cardiovasc Electrophysiol; 2014 Jul; 25(7):763-70. PubMed ID: 24602062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment.
    Piccini JP; Mittal S; Snell J; Prillinger JB; Dalal N; Varma N
    Heart Rhythm; 2016 Dec; 13(12):2279-2286. PubMed ID: 27544748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Safety and efficacy of classic ambulatory implantable cardioverter-defibrillator and resynchronisation systems follow-up compared to telemetric follow-up].
    Lelakowski J; Rydlewska A; Piekarz J; Lelakowska-Pieła M; Pudło J
    Pol Merkur Lekarski; 2016 Mar; 40(237):153-9. PubMed ID: 27088195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability of implantable cardioverter defibrillator home monitoring in forecasting the need for regular office visits, and patient perspective. Japanese HOME-ICD study.
    Watanabe E; Kasai A; Fujii E; Yamashiro K; Brugada P
    Circ J; 2013; 77(11):2704-11. PubMed ID: 23903000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remote monitoring of patients with cardiac implantable electronic devices: a Southeast Asian, single-centre pilot study.
    Lim PC; Lee AS; Chua KC; Lim ET; Chong DT; Tan BY; Ho KL; Teo WS; Ching CK
    Singapore Med J; 2016 Jul; 57(7):372-7. PubMed ID: 27439396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of an Organizational Management Model of Remote Implantable Cardioverter-Defibrillator Monitoring Alerts.
    Guédon-Moreau L; Finat L; Boulé S; Wissocque L; Marquié C; Brigadeau F; Kouakam C; Mondésert B; Kacet S; Klug D; Lacroix D
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):403-12. PubMed ID: 26105725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.
    El-Chami MF; Levy M; Kelli HM; Casey M; Hoskins MH; Goyal A; Langberg JJ; Patel A; Delurgio D; Lloyd MS; Leon AR; Merchant FM
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):900-904. PubMed ID: 25952566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies?
    Papavasileiou LP; Forleo GB; Panattoni G; Schirripa V; Minni V; Magliano G; Bellos K; Santini L; Romeo F
    J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):114-9. PubMed ID: 22644407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance with remote monitoring of ICDS/CRTDS in a real-world population.
    Rosenfeld LE; Patel AS; Ajmani VB; Holbrook RW; Brand TA
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):820-7. PubMed ID: 24484075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scheduled versus alert transmissions for remote follow-up of cardiac implantable electronic devices: Clinical relevance and resource consumption.
    Maines M; Tomasi G; Moggio P; Poian L; Peruzza F; Catanzariti D; Angheben C; Cont N; Valsecchi S; Del Greco M
    Int J Cardiol; 2021 Jul; 334():49-54. PubMed ID: 33930512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation.
    Mittal S; Piccini JP; Snell J; Prillinger JB; Dalal N; Varma N
    J Interv Card Electrophysiol; 2016 Aug; 46(2):129-36. PubMed ID: 26860839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remote monitoring of implantable devices: Should we continue to ignore it?
    Bertini M; Marcantoni L; Toselli T; Ferrari R
    Int J Cardiol; 2016 Jan; 202():368-77. PubMed ID: 26432486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of alert messages in the remote monitoring of implantable cardioverter defibrillators and pacemakers: an Italian single-region study.
    Folino AF; Chiusso F; Zanotto G; Vaccari D; Gasparini G; Megna A; Marras E; Mantovan R; Vaglio A; Boscolo G; Biancalana G; Leoni L; Iliceto S; Buja G
    Europace; 2011 Sep; 13(9):1281-91. PubMed ID: 21642369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
    Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
    Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.